Cargando…
Acteoside inhibits autophagic apoptosis of retinal ganglion cells to rescue glaucoma‐induced optic atrophy
BACKGROUND: Glaucoma is the world's second biggest cause of blindness, and patients progressively lose their eyesight. The current clinical treatment for glaucoma involves controlling intraocular pressure with drugs or surgery; however, some patients still progressively lose their eyesight. Thi...
Autores principales: | Chen, Qianbo, Xi, Xiaoting, Zeng, Yong, He, Zhendan, Zhao, Jianfeng, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618276/ https://www.ncbi.nlm.nih.gov/pubmed/31021425 http://dx.doi.org/10.1002/jcb.28586 |
Ejemplares similares
-
Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation
por: Xi, Xiaoting, et al.
Publicado: (2022) -
Acteoside attenuates hydrogen peroxide-induced injury of retinal ganglion cells via the CASC2/miR-155/mTOR axis
por: Xi, Xiaoting, et al.
Publicado: (2022) -
Retinal Ganglion Cell Dendritic Atrophy in DBA/2J Glaucoma
por: Williams, Pete A., et al.
Publicado: (2013) -
Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma
por: Ju, Won-Kyu, et al.
Publicado: (2010) -
Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
por: Hu, Xinxin, et al.
Publicado: (2018)